Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer

Published:2022-08-01 Issue:15 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Huang He^ORCID,Nie Cai-ping,Liu Xiu-feng,Song Bin,Yue Jian-hui^ORCID,Xu Jing-xiao,He Jia,Li Kui,Feng Yan-ling,Wan Ting,Zheng Min,Zhang Yan-Na,Ye Wei-Jun,Li Jun-Dong,Li Yan-Fang,Li Jun-yun,Cao Xin-Ping^ORCID,Liu Zhi-min,Zhang Xiao-shi,Liu Qing,Zhang Xi,Liu Ji-Hong,Li Jiang^ORCID

Funder

National Natural Science Foundation of China

Sci-Tech Key Program of the Guangzhou City Science Foundation

Guangdong Province Sci-Tech International Key Program

National Key R&D Program

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/157726/files/pdf

Reference59 articles.

2. Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research

3. Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials

4. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines

5. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy;Biomarker Research;2024-09-04

2. Frontiers and challenges of immune cell therapy research in solid tumors;Chinese Science Bulletin;2024-08-20

3. Applications of cell therapy in the treatment of virus-associated cancers;Nature Reviews Clinical Oncology;2024-08-19

4. Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy;Clinical and Translational Oncology;2024-07-30

5. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment;Nature Reviews Cancer;2024-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3